Stay updated with breaking news from Trilogy Writing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chairman and CEO Manish Gupta of Indegene says that a portion of the IPO proceeds will be used to repay debt, which includes interest costs associated with a previous loan. This, according to him, will boost the company's profitability.
Check out this week’s medical marketing news, dealmaking and industry chatter.
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy...
PRINCETON, N.J. and FRANKFURT, Germany, March 27, 2024 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing experti
/PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "AI in Medical Writing Market Share, Size, Trends, Industry Analysis...